Gie Yu, MD
Colon & Rectal Surgery · Atlanta, GANPI 1962608448
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,337 of the $2,755 with a category attached, or 84.8%. 29 manufacturers reported payments, led by Medtronic at 25.7% of the total. That places this record below the midpoint for colon & rectal surgery clinicians in GA, where the typical reported total is $4,045.
Across 76 payments — averaging $36.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$707
- Takeda Pharmaceuticals U.S.A., Inc.$284
- Davol Inc.$268
- Acell, Inc.$249
- AbbVie$155
- Axonics, Inc.$141
- plus $950 from 23 others
Across 14 payments — averaging $148.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Travel & lodging$41815%
- Food & beverage$2,33785%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $707 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $284 |
| Davol Inc. | 4 | $268 |
| Acell, Inc. | 5 | $249 |
| AbbVie(2 entities) | 2 | $155 |
| Axonics, Inc. | 3 | $141 |
| Dilon Technologies, Inc. | 1 | $135 |
| Baxter Healthcare | 4 | $100 |
| Aroa Biosurgery Incorporated | 1 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Innovation Technologies Inc | 1 | $70 |
| Braintree Laboratories, Inc. | 3 | $57 |
| Intuitive Surgical | 3 | $55 |
| Mimedx Group, Inc. | 2 | $36 |
| Johnson & Johnson | 1 | $33 |
| Lexington Medical, Inc. | 1 | $29 |
| Vertex | 1 | $28 |
| La Jolla Pharmaceutical Company | 1 | $26 |
| Merck | 2 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $22 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $22 |
| TELA Bio, Inc. | 2 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Palette Life Sciences, Inc. | 1 | $18 |
| THD America, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Solventum Corporation | 1 | $14 |
| Prescient Surgical | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$418
- Surgiphor$192
- STRATTICE$136
- HemoBlast Bellows$135
- Axonics r-SNM System$112
How this compares
$2,755 in reported general payments places this provider in the 40th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 49 | $3,228 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 13 | $2,221 |
| Hydrocortisone | 46 | $335 |
| Metronidazole | 34 | $281 |
| Lidocaine | 11 | $201 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $181 |
| Ciprofloxacin Hcl | 14 | $138 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $126 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $100 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $69 |
| Oxycodone Hcl | 16 | $59 |
| Neomycin Sulfate | 19 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ferring Pharmaceuticals Inc.Clenpiq | $19 | $2,22113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 66 colon & rectal surgery providers in Georgia.
Other colon & rectal surgery in Atlanta
- Patrick SullivanAtlanta$41K
- Sander BinderowAtlanta$20K
- Daniel Sarmiento GarzonAtlanta$14K
- Joseph MarenoAtlanta$13K
- Jessica LamAtlanta$8K
- Evan FeldmanAtlanta$7K
- Cici ZhangAtlanta$5K
- Ellen CaparosaAtlanta$5K
- Monica HumAtlanta$5K
- Stephanie PappasAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.